欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1537/002
药品名称Zoreeda
活性成分
    • fluticasone 250.0 µg
    • salmeterol 25.0 µg
剂型Pressurised inhalation, suspension
上市许可持有人Cipla Europe NV Belgium
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Czechia (CZ)
      Salmeterolum/Fluticasoni Cipla 25 mikrogramů/250 mikrogramů/dávka Suspenze k inhalaci v tlakovém oba
    • Germany (DE)
      Salmeterol/Fluticasonpropionat Cipla 25 Mikrogramm/250 Mikrogramm pro Sprühstoß Druckgasinhalation,
许可日期2016/01/12
最近更新日期2021/02/24
药物ATC编码
    • R03AK06 salmeterol and fluticasone
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase